Advertisement

A Fertility Regulating Vaccine Based on the Carboxyl-Terminal Peptide of the Beta Subunit of Human Chorionic Gonadotrophin

  • P. D. Griffin
Part of the Reproductive Biology book series (RBIO)

Abstract

The World Health Organization’s Special Programme of Research, Development and Research Training in Human Reproduction was established in 1972 in response to requests from a number of its member states that the Organization take a more active role in family planning research. The methods of birth control available at that time did not, and to a large extent still do not, satisfy all of the varied cultural and service demands of different populations and there was an expressed need to develop a greater variety of methods which would find wide acceptance, particularly in developing countries. One of the principal objectives of the WHO Programme, therefore, is the development of new family planning technology to meet these demands. A safe and effective method which could be administered at infrequent intervals, perhaps by paramedical personnel, and which is independant of active participation by the user to remain effective, is attractive to both the users and providers of family planning services. The acceptability of such a method would be further enhanced if its activity is restricted to the intended target, it is devoid of pharmacological activity and it does not produce undesirable side-effects. A birth control vaccine, eliciting a specific, safe and effective antifertility immune response lasting for 1–2 years is likely, therefore, to have a major impact in family planning programmes.

Keywords

Corpus Luteum Tetanus Toxoid Beta Subunit Diphtheria Toxoid Female Baboon 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lee, A.C., Powell, J.E., Tregear, G.W., Niall, H.D., Stevens, V.C., 1980, A method for preparing β-hCG COOH peptide-carrier conjugates of predictable composition. Molecular Immunology, 17: 749–755.PubMedCrossRefGoogle Scholar
  2. Morgan, F.J., Birken, S., Canfield, R.E., 1973, Human chorionic gonadotropin:a proposal for the amino acid sequence. Molecular and Cellular Biochemistry, 2: 97–99.PubMedCrossRefGoogle Scholar
  3. Powell, J.E., Lee, A.C., Tregear, G.W., Niall, H.D., Stevens, V.C., 1980, Characteristics of antibodies raised to carboxy-terminal peptides of hCG beta subunit. Journal of Reproductive Immunology, 2: 1–13.CrossRefGoogle Scholar
  4. Puett, D., Ryan, R.J., Stevens, V.C., 1982, Circular dichroic and immunological properties of human choriogonadotropin-β carboxyl terminal peptides. International Journal of Peptide and Protein Research, 19: 506–513.PubMedCrossRefGoogle Scholar
  5. Stevens, V.C., Crystle, C.D., 1973, Effects of immunization with hapten-coupled hCG on the human menstrual cycle. Obstetrics and Gynecology, 42: 485–495.PubMedCrossRefGoogle Scholar
  6. Stevens, V.C., 1974, Fertility control through active immunization using placental proteins, in: Immunological Approaches to Fertility Control, Karolinska Symposium, 7, E. Diczfalusy, ed., Forum, Copenhagen.Google Scholar
  7. Stevens, V.C., 1976, Actions of antisera to hCG-β: In vitro and in vivo assessment, in: Proceedings of the Fifth International Congress of Endocrinology. Vol. 1: 379, Excerpta Medica International Congress Series No. 402, Hamburg.Google Scholar
  8. Stevens, V.C., Powell, J.E., Lee, A.C., Griffin, P.D., 1981a, Antifertility effects from immunization of female baboons with C-terminal peptides of hCG beta subunit. Fertility and Sterility, 36: 98–105.PubMedGoogle Scholar
  9. Stevens, V.C., Cinader, B., Powell, J.E., Lee, A.C., Koh, S.W., 1981b Preparation and formulation of a hCG antifertility vaccine. Selection of peptide immunogen. American Journal of Reproductive Immunology, 6: 307–314.Google Scholar
  10. Stevens, V.C., Cinader, B., Powell, J.E., Lee, A.C., Koh, S.W., 1981c, Preparation and formulation of a hCG antifertility vaccine. Selection of adjuvant and vehicle. American Journal of Reproductive Immunology, 6: 315–321.Google Scholar
  11. Talwar, G.P., Sharma, N.C., Dubey, S.K., Salahuddin, M., Das, C., Ramakrishnan, S., Kumar, S., Hingorani, V., 1976, Isoimmunization against human chorionic gonadotropin with con jugates of processed β-subunit of the hormone and tetanus toxoid. Proceedings of the National Academy of Sciences, USA 73, 218–222.Google Scholar
  12. WHO Special Programme of Research, Development and Research Training in Human Reproduction, 1984, Thirteenth Annual Report.Google Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • P. D. Griffin
    • 1
  1. 1.Special Programme of Research, Development and Research Training in Human ReproductionWorld Health OrganizationGenevaSwitzerland

Personalised recommendations